Here's Why You Should Retain CLOV Stock in Your Portfolio for Now

Key Takeaways CLOV's share rising with 53% membership growth and expects GAAP profit in 2026, backed by retention above 95%.CLOV sees higher margins as Clover Assistant drives profits and improves cost ratios for returning members.CLOV expands monetization through Counterpart Health, extending its platform beyond Medicare Advantage plans.Clover Health Investments (CLOV) is well poised for growth in the coming quarters, courtesy of its broad product spectrum. This optimism is primarily driven by its technolo ...